Market cap
₹58 Cr
Revenue (TTM)
₹62 Cr
P/E Ratio
--
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹5 Cr
-
ROE
12.2 %
-
ROCE
13.7 %
-
Industry P/E
47.01
-
EV/EBITDA
16.1
-
Debt to Equity
0.2
-
Book Value
₹30.7
-
EPS
₹2.7
-
Face value
10
-
Shares outstanding
18,132,200
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Onyx Biotec
| -21.6 | -2.3 | -8.8 | -38.0 | -- | -- | -- |
|
BSE Healthcare
| 9.5 | 9.4 | 9.8 | 12.1 | 27.6 | 14.5 | 11.8 |
|
Company
|
2025
|
|---|---|
|
Onyx Biotec
| -55.9 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Onyx Biotec
|
32.0 | 58.0 | 62.0 | 5.0 | -- | 12.2 | -- | 1.0 |
| 993.0 | 1,724.7 | 77.0 | 16.4 | -- | 43.4 | 109.2 | 16.1 | |
| 94.0 | 34.3 | 54.6 | -1.1 | 3.6 | -3.5 | -- | 1.2 | |
| 2,251.1 | 37,049.6 | 6,430.7 | 1,027.3 | 18.8 | 10.5 | 36.1 | 3.6 | |
| 132.8 | 43.8 | 13.9 | 0.4 | -- | 5.6 | 99.6 | 5.4 | |
| 204.2 | 1,110.2 | 264.6 | 19.3 | 8.9 | 6.2 | 47.9 | 4.8 | |
| 934.7 | 11,285.1 | 6,537.7 | 207.0 | 4.6 | 11.5 | 54.5 | 5.9 | |
| 40.0 | 71.2 | 167.8 | 5.9 | -- | 5.7 | 12.2 | 0.7 | |
| 134.0 | 71.7 | 61.7 | 6.3 | -- | 28.9 | 11.3 | 2.3 | |
| 128.8 | 49.0 | 20.6 | 2.5 | 18.7 | 16.9 | 19.7 | 2.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Onyx Biotec
--
-
Incorporated
2005
-
Chairman
--
-
Managing Director
Sanjay Jain
-
Headquarters
Solan, Himachal Pradesh
-
Website
Looking for more details about Onyx Biotec Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Onyx Biotec
What is the current share price of Onyx Biotec Ltd Today?
The share price of Onyx Biotec Ltd is ₹32.00 (NSE) as of 19-May-2026 IST. Onyx Biotec Ltd has given a return of -37.98% in the last 1 years.
What is the current PB & PE ratio of Onyx Biotec Ltd?
Since, TTM earnings of Onyx Biotec Ltd is negative, P/E ratio is not available.
The P/B ratio of Onyx Biotec Ltd is 1.04 times as on 18-May-2026, a 53 discount to its peers’ median range of 2.23 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
21.23
|
1.89
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2025
|
21.23
|
1.89
|
What is the 52 Week High and Low of Onyx Biotec Ltd?
The 52-week high and low of Onyx Biotec Ltd are Rs 56.00 and Rs 28.10 as of 19-May-2026.
What is the market cap of Onyx Biotec Ltd?
Onyx Biotec Ltd has a market capitalisation of ₹ 58 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Onyx Biotec Ltd?
Before investing in Onyx Biotec Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.